DNAtix's use of the blockchain method to pay for genetic tests maintains the total confidentiality of the person giving the sample.
The facility is designed for purification of rhCollagen and formulation of end-products, including BioInks for 3D bioprinting and its proprietary tissue repair products.
Enlivex is developing a treatment for Graft-versus-Host disease (GvHD) resulting from bone-marrow transplants.
Medical cannabis supplier BOL's products at Super-Pharm will be priced at NIS 120-140 per 10 grams.
The separation follows Procter & Gamble's $4.2 billion acquisition of Merck's consumer health unit.
The company's first product treated incontinence while its latest insert is for pelvic prolapse.
The fund, led by Marius Nacht and Dr. Yair Schindel, is planned to reach $500 million.
The Histadrut has demanded that Teva immediately suspend plans to close its Ashdod plant.
Globus Pharma has signed a MoU to sell 50 tons of medical cannabis to a Canadian company.
It is unclear whether medical cannabis exports will be permitted, but share prices of companies in the industry are soaring.
200,000 Syrians near the border look to Israel for help. Children get top priority, and not only the wounded. "Globes" visits the Golan and travels with patients to Galilee hospitals.
MIXiii-BIOMED 2018 Conference chair Ruti Alon: The pendulum has to move back to medical devices, after a decade in which the sector was starved of financing.